{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:01:08Z","timestamp":1791198068878,"version":"4.1.0"},"reference-count":196,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005010","name":"We are grateful to the Italian Association for Cancer Research","doi-asserted-by":"publisher","award":["IG 11814"],"award-info":[{"award-number":["IG 11814"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Italian Ministry of Education","award":["2010CSJX4F"],"award-info":[{"award-number":["2010CSJX4F"]}]},{"name":"Italian Ministry of Education","award":["20107Z8XBW_004"],"award-info":[{"award-number":["20107Z8XBW_004"]}]},{"name":"DFG","award":["GU 335\/29-1"],"award-info":[{"award-number":["GU 335\/29-1"]}]},{"name":"Iontrac Marie-Curie Training Network","award":["289648"],"award-info":[{"award-number":["289648"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.bbamcr.2015.11.032","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T18:04:33Z","timestamp":1448906673000},"page":"1385-1397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"special_numbering":"PB","title":["Pharmacological targeting of ion channels for cancer therapy: In vivo evidences"],"prefix":"10.1016","volume":"1863","author":[{"given":"Luigi","family":"Leanza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Manag\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Zoratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erich","family":"Gulbins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ildiko","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/iub.1266","article-title":"Functions of volume-sensitive and calcium-activated chloride channels","volume":"66","author":"Hoffmann","year":"2014","journal-title":"IUBMB Life"},{"issue":"5\u20136","key":"10.1016\/j.bbamcr.2015.11.032_bb0010","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1159\/000016367","article-title":"Cell volume in the regulation of cell proliferation and apoptotic cell death","volume":"10","author":"Lang","year":"2000","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0015","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3390\/cancers7020813","article-title":"Voltage-gated ion channels in cancer cell proliferation","volume":"7","author":"Rao","year":"2015","journal-title":"Cancers (Basel)"},{"issue":"1\u20132","key":"10.1016\/j.bbamcr.2015.11.032_bb0020","first-page":"48","article-title":"The biological significance of cell volume","volume":"16","author":"Lang","year":"1993","journal-title":"Ren. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0025","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1152\/physrev.1992.72.4.1037","article-title":"Calcium signaling in cell volume regulation","volume":"72","author":"McCarty","year":"1992","journal-title":"Physiol. Rev."},{"issue":"10","key":"10.1016\/j.bbamcr.2015.11.032_bb0030","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/j.febslet.2010.01.038","article-title":"Contribution of voltage-gated potassium channels to the regulation of apoptosis","volume":"584","author":"Szabo","year":"2010","journal-title":"FEBS Lett."},{"issue":"10 Pt B","key":"10.1016\/j.bbamcr.2015.11.032_bb0035","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/j.bbamem.2014.10.030","article-title":"Ion channels in the regulation of apoptosis","volume":"1848","author":"Kondratskyi","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"1638","key":"10.1016\/j.bbamcr.2015.11.032_bb0040","doi-asserted-by":"crossref","first-page":"20130104","DOI":"10.1098\/rstb.2013.0104","article-title":"Ion channels and apoptosis in cancer","volume":"369","author":"Bortner","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00424-004-1258-5","article-title":"Roles of K+ channels in regulating tumour cell proliferation and apoptosis","volume":"448","author":"Wang","year":"2004","journal-title":"Pflugers Arch."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0050","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1152\/physrev.00018.2011","article-title":"Role of ion channels and transporters in cell migration","volume":"92","author":"Schwab","year":"2012","journal-title":"Physiol. Rev."},{"issue":"1638","key":"10.1016\/j.bbamcr.2015.11.032_bb0055","doi-asserted-by":"crossref","first-page":"20130102","DOI":"10.1098\/rstb.2013.0102","article-title":"Ion channels and transporters in tumour cell migration and invasion","volume":"369","author":"Schwab","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0060","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3389\/fncel.2015.00086","article-title":"Cancer as a channelopathy: ion channels and pumps in tumor development and progression","volume":"9","author":"Litan","year":"2015","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0065","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1083\/jcb.143.3.767","article-title":"Cell cycle-related changes in the conducting properties of r-eag K+ channels","volume":"143","author":"Pardo","year":"1998","journal-title":"J. Cell Biol."},{"issue":"20","key":"10.1016\/j.bbamcr.2015.11.032_bb0070","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1093\/emboj\/18.20.5540","article-title":"Oncogenic potential of EAG K(+) channels","volume":"18","author":"Pardo","year":"1999","journal-title":"Embo j"},{"issue":"5","key":"10.1016\/j.bbamcr.2015.11.032_bb0075","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1083\/jcb.122.5.1131","article-title":"Integrin-mediated neurite outgrowth in neuroblastoma cells depends on the activation of potassium channels","volume":"122","author":"Arcangeli","year":"1993","journal-title":"J. Cell Biol."},{"issue":"34","key":"10.1016\/j.bbamcr.2015.11.032_bb0080","first-page":"20465","article-title":"Tyrosine phosphorylation-dependent suppression of a voltage-gated K+ channel in T lymphocytes upon Fas stimulation","volume":"271","author":"Szabo","year":"1996","journal-title":"J. Biolumin. Chemilumin."},{"issue":"11","key":"10.1016\/j.bbamcr.2015.11.032_bb0085","doi-asserted-by":"crossref","first-page":"6169","DOI":"10.1073\/pnas.95.11.6169","article-title":"Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes","volume":"95","author":"Szabo","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2\u20133","key":"10.1016\/j.bbamcr.2015.11.032_bb0090","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0014-5793(95)00772-2","article-title":"Differential expression of voltage-activated Na+ currents in two prostatic tumour cell lines: contribution to invasiveness in vitro","volume":"369","author":"Grimes","year":"1995","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.bbamcr.2015.11.032_bb0095","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0100","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fphys.2013.00227","article-title":"Intracellular ion channels and cancer","volume":"4","author":"Leanza","year":"2013","journal-title":"Front. Physiol."},{"issue":"49","key":"10.1016\/j.bbamcr.2015.11.032_bb0105","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.1038\/onc.2013.578","article-title":"Mitochondrial ion channels as oncological targets","volume":"33","author":"Leanza","year":"2014","journal-title":"Oncogene"},{"issue":"1638","key":"10.1016\/j.bbamcr.2015.11.032_bb0110","doi-asserted-by":"crossref","first-page":"20130094","DOI":"10.1098\/rstb.2013.0094","article-title":"Potassium channels in cell cycle and cell proliferation","volume":"369","author":"Urrego","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0115","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrc3635","article-title":"The roles of K(+) channels in cancer","volume":"14","author":"Pardo","year":"2014","journal-title":"Nat. Rev. Cancer"},{"issue":"1638","key":"10.1016\/j.bbamcr.2015.11.032_bb0120","doi-asserted-by":"crossref","first-page":"20130109","DOI":"10.1098\/rstb.2013.0109","article-title":"Ion channels and transporters in the development of drug resistance in cancer cells","volume":"369","author":"Hoffmann","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"10 Pt B","key":"10.1016\/j.bbamcr.2015.11.032_bb0125","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1016\/j.bbamem.2014.10.031","article-title":"Systems biology of ion channels and transporters in tumor angiogenesis: An omics view","volume":"1848","author":"Munaron","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0130","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1574892811308010066","article-title":"Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease","volume":"8","author":"Djamgoz","year":"2013","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.semcancer.2013.08.011","article-title":"The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: insight into disease biology and new targeted therapies","volume":"24","author":"Burger","year":"2014","journal-title":"Semin. Cancer Biol."},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0140","doi-asserted-by":"crossref","first-page":"537","DOI":"10.4161\/cbt.10.6.13370","article-title":"Understanding the \u201clethal\u201d drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy\/mitophagy in the tumor micro-environment","volume":"10","author":"Lisanti","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0145","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000362978","article-title":"Cell-cell communication in the tumor microenvironment, carcinogenesis, and anticancer treatment","volume":"34","author":"Brucher","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"10 Pt B","key":"10.1016\/j.bbamcr.2015.11.032_bb0150","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1016\/j.bbamem.2014.08.016","article-title":"Altered calcium signaling in cancer cells","volume":"1848","author":"Stewart","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"9","key":"10.1016\/j.bbamcr.2015.11.032_bb0155","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrm3412","article-title":"Mitochondria as sensors and regulators of calcium signalling","volume":"13","author":"Rizzuto","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0160","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fphys.2013.00272","article-title":"Calcium-permeable ion channels in control of autophagy and cancer","volume":"4","author":"Kondratskyi","year":"2013","journal-title":"Front. Physiol."},{"issue":"Pt 2","key":"10.1016\/j.bbamcr.2015.11.032_bb0165","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1242\/jeb.200.2.303","article-title":"Intracellular Ca2+ signalling in secretory cells","volume":"200","author":"Shuttleworth","year":"1997","journal-title":"J Exp Biol"},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0170","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/978-3-319-05161-1_13","article-title":"The TRPCs\u2013STIM1\u2013Orai interaction","volume":"223","author":"Choi","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-12-407870-3.00007-X","article-title":"Contribution and regulation of TRPC channels in store-operated Ca2+ entry","volume":"71","author":"Cheng","year":"2013","journal-title":"Curr. Top. Membr."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0180","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1111\/bph.12486","article-title":"Calcium influx pathways in breast cancer: opportunities for pharmacological intervention","volume":"171","author":"Azimi","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceca.2015.02.006","article-title":"Organellar channels and transporters","volume":"58","author":"Xu","year":"2015","journal-title":"Cell Calcium"},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0190","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ceca.2014.12.005","article-title":"Evolution of acidic Ca(2)(+) stores and their resident Ca(2)(+)-permeable channels","volume":"57","author":"Patel","year":"2015","journal-title":"Cell Calcium"},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molmed.2010.01.005","article-title":"Ion channels and the hallmarks of cancer","volume":"16","author":"Prevarskaya","year":"2010","journal-title":"Trends Mol. Med."},{"issue":"11","key":"10.1016\/j.bbamcr.2015.11.032_bb0200","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1023\/A:1026556119020","article-title":"Verapamil increases the survival of patients with anthracycline-resistant metastatic breast carcinoma","volume":"11","author":"Belpomme","year":"2000","journal-title":"Ann. Oncol."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0205","doi-asserted-by":"crossref","first-page":"F765","DOI":"10.1152\/ajprenal.00253.2001","article-title":"On the natriuretic effect of verapamil: inhibition of ENaC and transepithelial sodium transport","volume":"283","author":"Segal","year":"2002","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0210","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/j.1745-7254.2007.00562.x","article-title":"Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain","volume":"28","author":"Duan","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/00005344-200308000-00002","article-title":"Verapamil, a Ca2+ entry blocker, targets the pore-forming subunit of cardiac type KATP channel (Kir6.2)","volume":"42","author":"Ninomiya","year":"2003","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0220","first-page":"1132","article-title":"Binding of an optically pure photoaffinity analogue of verapamil, LU-49888, to P-glycoprotein from multidrug-resistant human leukemic cell lines","volume":"50","author":"Qian","year":"1990","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.bbamcr.2015.11.032_bb0225","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1227\/01.NEU.0000245597.46581.FB","article-title":"Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro","volume":"59","author":"Ragel","year":"2006","journal-title":"Neurosurgery"},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0230","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/FOC-07\/10\/E10","article-title":"Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas","volume":"23","author":"Ragel","year":"2007","journal-title":"Neurosurg. Focus."},{"issue":"9","key":"10.1016\/j.bbamcr.2015.11.032_bb0235","first-page":"2413","article-title":"Inhibition of cancer cell growth by calcium channel antagonists in the athymic mouse","volume":"52","author":"Taylor","year":"1992","journal-title":"Cancer Res."},{"issue":"1\u20132","key":"10.1016\/j.bbamcr.2015.11.032_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-2999(03)01831-4","article-title":"Antiproliferative effect of Ca2+ channel blockers on human epidermoid carcinoma A431 cells","volume":"472","author":"Yoshida","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0245","first-page":"279","article-title":"The epidermal growth factor-induced calcium signal in A431 cells","volume":"261","author":"Moolenaar","year":"1986","journal-title":"J. Biolumin. Chemilumin."},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0250","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.bcp.2006.12.011","article-title":"G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells","volume":"73","author":"Yoshida","year":"2007","journal-title":"Biochem. Pharmacol."},{"issue":"3\u20134","key":"10.1016\/j.bbamcr.2015.11.032_bb0255","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lfs.2009.11.014","article-title":"Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells","volume":"86","author":"Yoshida","year":"2010","journal-title":"Life Sci."},{"issue":"29","key":"10.1016\/j.bbamcr.2015.11.032_bb0260","first-page":"27208","article-title":"Caveolin-1 contributes to assembly of store-operated Ca2+ influx channels by regulating plasma membrane localization of TRPC1","volume":"278","author":"Brazer","year":"2003","journal-title":"J. Biolumin. Chemilumin."},{"issue":"20","key":"10.1016\/j.bbamcr.2015.11.032_bb0265","first-page":"16146","article-title":"TRPC1 protein channel is major regulator of epidermal growth factor receptor signaling","volume":"287","author":"Tajeddine","year":"2012","journal-title":"J. Biolumin. Chemilumin."},{"issue":"23","key":"10.1016\/j.bbamcr.2015.11.032_bb0270","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.bmcl.2012.09.076","article-title":"T-type Ca2+ channel blocker, KYS05047 induces G1 phase cell cycle arrest by decreasing intracellular Ca2+ levels in human lung adenocarcinoma A549 cells","volume":"22","author":"Rim","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0275","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bmcl.2004.10.078","article-title":"Synthesis and biological activity of 3,4-dihydroquinazolines for selective T-type Ca2+ channel blockers","volume":"15","author":"Rhim","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"12","key":"10.1016\/j.bbamcr.2015.11.032_bb0280","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1158\/0008-5472.CAN-05-0271","article-title":"Calcium\/calmodulin-dependent kinase I and calcium\/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells","volume":"65","author":"Rodriguez-Mora","year":"2005","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0285","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0022-3565(25)24034-4","article-title":"The Ca(++)-channel blocker Ro 40-5967 blocks differently T-type and L-type Ca++ channels","volume":"271","author":"Mehrke","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0290","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3171\/2012.11.JNS121087","article-title":"Inhibition of glioblastoma and enhancement of survival via the use of mibefradil in conjunction with radiosurgery","volume":"118","author":"Sheehan","year":"2013","journal-title":"J. Neurosurg."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0295","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-012-0995-0","article-title":"Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model","volume":"111","author":"Keir","year":"2013","journal-title":"J. Neuro-Oncol."},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0300","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00417-004-0886-y","article-title":"Induction of apoptosis by the calcium antagonist mibefradil correlates with depolarization of the membrane potential and decreased integrin expression in human lens epithelial cells","volume":"242","author":"Nebe","year":"2004","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"5","key":"10.1016\/j.bbamcr.2015.11.032_bb0305","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00109-014-1235-1","article-title":"NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1alpha signal transduction","volume":"93","author":"Kim","year":"2015","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0310","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1096\/fj.05-5086com","article-title":"Calcium signaling stimulates translation of HIF-alpha during hypoxia","volume":"20","author":"Hui","year":"2006","journal-title":"FASEB J."},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0315","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1476-5381.2009.00117.x","article-title":"Artemisinin induces doxorubicin resistance in human colon cancer cells via calcium-dependent activation of HIF-1alpha and P-glycoprotein overexpression","volume":"156","author":"Riganti","year":"2009","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.bbamcr.2015.11.032_bb0320","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejphar.2009.01.012","article-title":"The calcium channel blocker cilnidipine selectively suppresses hypoxia-inducible factor 1 activity in vascular cells","volume":"606","author":"Oda","year":"2009","journal-title":"Eur. J. Pharmacol."},{"issue":"52","key":"10.1016\/j.bbamcr.2015.11.032_bb0325","first-page":"36284","article-title":"A splice variant of the human ion channel TRPM2 modulates neuroblastoma tumor growth through hypoxia-inducible factor (HIF)-1\/2alpha","volume":"289","author":"Chen","year":"2014","journal-title":"J. Biolumin. Chemilumin."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0330","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ijc.23593","article-title":"Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice","volume":"123","author":"Cho","year":"2008","journal-title":"Int. J. Cancer"},{"issue":"51","key":"10.1016\/j.bbamcr.2015.11.032_bb0335","first-page":"35075","article-title":"Simvastatin potently induces calcium-dependent apoptosis of human leiomyoma cells","volume":"289","author":"Borahay","year":"2014","journal-title":"J. Biolumin. Chemilumin."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0340","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00424-014-1444-z","article-title":"T-type calcium channels blockers as new tools in cancer therapies","volume":"466","author":"Dziegielewska","year":"2014","journal-title":"Pflugers Arch."},{"issue":"10 Pt B","key":"10.1016\/j.bbamcr.2015.11.032_bb0345","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1016\/j.bbamem.2015.06.009","article-title":"Plasma membrane calcium channels in cancer: alterations and consequences for cell proliferation and migration","volume":"1848","author":"Deliot","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"10","key":"10.1016\/j.bbamcr.2015.11.032_bb0350","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/glia.20994","article-title":"Disruption of transient receptor potential canonical channel 1 causes incomplete cytokinesis and slows the growth of human malignant gliomas","volume":"58","author":"Bomben","year":"2010","journal-title":"Glia"},{"issue":"10","key":"10.1016\/j.bbamcr.2015.11.032_bb0355","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1111\/bph.12561","article-title":"New insights into pharmacological tools to TR(i)P cancer up","volume":"171","author":"Gautier","year":"2014","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0360","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bph.12274","article-title":"In pursuit of small molecule chemistry for calcium-permeable non-selective TRPC channels \u2014 mirage or pot of gold?","volume":"170","author":"Bon","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbamcr.2015.11.032_bb0365","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1002\/anie.201411511","article-title":"(\u2212)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels","volume":"54","author":"Akbulut","year":"2015","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127498","article-title":"Englerin A agonizes the TRPC4\/C5 cation channels to inhibit tumor cell line proliferation","volume":"10","author":"Carson","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0375","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jnutbio.2012.08.008","article-title":"20-O-beta-d-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginseng, inhibits colon cancer growth by targeting TRPC channel-mediated calcium influx","volume":"24","author":"Hwang","year":"2013","journal-title":"J. Nutr. Biochem."},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ceca.2010.11.007","article-title":"Heavy metal cations permeate the TRPV6 epithelial cation channel","volume":"49","author":"Kovacs","year":"2011","journal-title":"Cell Calcium"},{"issue":"37","key":"10.1016\/j.bbamcr.2015.11.032_bb0385","doi-asserted-by":"crossref","first-page":"E3870","DOI":"10.1073\/pnas.1413409111","article-title":"TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival","volume":"111","author":"Raphael","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0390","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/978-94-007-0265-3_48","article-title":"Oncogenic TRP channels","volume":"704","author":"Lehen'kyi","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0395","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s11095-010-0249-9","article-title":"Chemical inhibitors of the calcium entry channel TRPV6","volume":"28","author":"Landowski","year":"2011","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.bbamcr.2015.11.032_bb0400","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1016\/j.bmc.2013.03.037","article-title":"Design, synthesis and pharmacological characterization of analogs of 2-aminoethyl diphenylborinate (2-APB), a known store-operated calcium channel blocker, for inhibition of TRPV6-mediated calcium transport","volume":"21","author":"Hofer","year":"2013","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058866","article-title":"In vivo detection of human TRPV6-rich tumors with anti-cancer peptides derived from soricidin","volume":"8","author":"Bowen","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbamcr.2015.11.032_bb0410","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s10495-014-1007-y","article-title":"Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathway","volume":"19","author":"Lau","year":"2014","journal-title":"Apoptosis"},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0415","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.urology.2009.03.042","article-title":"Capsaicin mediates cell death in bladder cancer T24 cells through reactive oxygen species production and mitochondrial depolarization","volume":"75","author":"Yang","year":"2010","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0420","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cellsig.2013.09.014","article-title":"Capsaicin induces cytotoxicity in pancreatic neuroendocrine tumor cells via mitochondrial action","volume":"26","author":"Skrzypski","year":"2014","journal-title":"Cell. Signal."},{"issue":"5","key":"10.1016\/j.bbamcr.2015.11.032_bb0425","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.oraloncology.2013.12.023","article-title":"Vanilloids induce oral cancer apoptosis independent of TRPV1","volume":"50","author":"Gonzales","year":"2014","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0430","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s10495-005-3275-z","article-title":"Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin","volume":"11","author":"Sanchez","year":"2006","journal-title":"Apoptosis"},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0435","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0440","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.1476-5381.2010.01166.x","article-title":"Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes","volume":"163","author":"De Petrocellis","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0445","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.bcp.2009.11.007","article-title":"Cannabidiol inhibits cancer cell invasion via upregulation of tissue inhibitor of matrix metalloproteinases-1","volume":"79","author":"Ramer","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0450","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1096\/fj.11-198184","article-title":"Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule-1","volume":"26","author":"Ramer","year":"2012","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0455","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1476-5381.2012.02027.x","article-title":"Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms","volume":"168","author":"De Petrocellis","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbamcr.2015.11.032_bb0460","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/carcin\/bgu205","article-title":"Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid","volume":"35","author":"Borrelli","year":"2014","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0465","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ceca.2010.01.006","article-title":"Differential roles of STIM1, STIM2 and Orai1 in the control of cell proliferation and SOCE amplitude in HEK293 cells","volume":"47","author":"El Boustany","year":"2010","journal-title":"Cell Calcium"},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0470","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ccr.2014.04.025","article-title":"Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer","volume":"26","author":"Dubois","year":"2014","journal-title":"Cancer Cell"},{"issue":"50","key":"10.1016\/j.bbamcr.2015.11.032_bb0475","doi-asserted-by":"crossref","first-page":"E4839","DOI":"10.1073\/pnas.1310394110","article-title":"ORAI1 calcium channel orchestrates skin homeostasis","volume":"110","author":"Vandenberghe","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0480","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1038\/cddis.2010.52","article-title":"Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells","volume":"1","author":"Flourakis","year":"2010","journal-title":"Cell Death Dis"},{"issue":"11","key":"10.1016\/j.bbamcr.2015.11.032_bb0485","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.18632\/oncotarget.1903","article-title":"Elevated Orai1 expression mediates tumor-promoting intracellular Ca2+ oscillations in human esophageal squamous cell carcinoma","volume":"5","author":"Zhu","year":"2014","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0490","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0021-5198(19)30761-9","article-title":"Current perspectives in the pharmacological studies of store-operated Ca2+ entry blockers","volume":"81","author":"Leung","year":"1999","journal-title":"Jpn. J. Pharmacol."},{"issue":"37","key":"10.1016\/j.bbamcr.2015.11.032_bb0495","doi-asserted-by":"crossref","first-page":"15225","DOI":"10.1073\/pnas.1103315108","article-title":"Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis","volume":"108","author":"Chen","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bbamcr.2015.11.032_bb0500","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1096\/fj.02-0037rev","article-title":"2-aminoethoxydiphenyl borate (2-APB) is a reliable blocker of store-operated Ca2+ entry but an inconsistent inhibitor of InsP3-induced Ca2+ release","volume":"16","author":"Bootman","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0505","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-3-540-34891-7_10","article-title":"2-Aminoethoxydiphenyl borate as a common activator of TRPV1, TRPV2, and TRPV3 channels","volume":"179","author":"Colton","year":"2007","journal-title":"Handb. Exp. Pharmacol."},{"issue":"6112","key":"10.1016\/j.bbamcr.2015.11.032_bb0510","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1126\/science.1228757","article-title":"Crystal structure of the calcium release-activated calcium channel Orai","volume":"338","author":"Hou","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0515","article-title":"SOCE and cancer: recent progress and new perspectives","author":"Xie","year":"2015","journal-title":"Int. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0520","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/MPA.0b013e318030e963","article-title":"Statins reduce the risk of pancreatic cancer in humans: a case\u2013control study of half a million veterans","volume":"34","author":"Khurana","year":"2007","journal-title":"Pancreas"},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0525","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1053\/gast.2002.31093","article-title":"3-Hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors reduce human pancreatic cancer cell invasion and metastasis","volume":"122","author":"Kusama","year":"2002","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bbamcr.2015.11.032_bb0530","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bcp.2009.06.016","article-title":"Statins inhibit Akt\/PKB signaling via P2X7 receptor in pancreatic cancer cells","volume":"78","author":"Mistafa","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"10 Pt B","key":"10.1016\/j.bbamcr.2015.11.032_bb0535","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.bbamem.2014.10.029","article-title":"Understanding the roles of the P2X7 receptor in solid tumour progression and therapeutic perspectives","volume":"1848","author":"Roger","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002599","article-title":"Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase","volume":"3","author":"Pellegatti","year":"2008","journal-title":"PLoS One"},{"issue":"18","key":"10.1016\/j.bbamcr.2015.11.032_bb0545","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1038\/onc.2010.593","article-title":"P2X(7) receptor activation enhances SK3 channels- and cystein cathepsin-dependent cancer cells invasiveness","volume":"30","author":"Jelassi","year":"2011","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0550","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1093\/carcin\/bgt099","article-title":"Anthraquinone emodin inhibits human cancer cell invasiveness by antagonizing P2X7 receptors","volume":"34","author":"Jelassi","year":"2013","journal-title":"Carcinogenesis"},{"issue":"1\u20133","key":"10.1016\/j.bbamcr.2015.11.032_bb0555","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2012.09.001","article-title":"Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7","volume":"695","author":"Hattori","year":"2012","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbamcr.2015.11.032_bb0560","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1158\/0008-5472.CAN-11-1947","article-title":"Expression of P2X7 receptor increases in vivo tumor growth","volume":"72","author":"Adinolfi","year":"2012","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0565","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s11302-009-9156-0","article-title":"An in vivo model of melanoma: treatment with ATP","volume":"5","author":"White","year":"2009","journal-title":"Purinergic Signal"},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0570","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1152\/physrev.00036.2011","article-title":"hERG K(+) channels: structure, function, and clinical significance","volume":"92","author":"Vandenberg","year":"2012","journal-title":"Physiol. Rev."},{"issue":"Pt 2","key":"10.1016\/j.bbamcr.2015.11.032_bb0575","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1113\/jphysiol.1995.sp021065","article-title":"A novel inward-rectifying K+ current with a cell-cycle dependence governs the resting potential of mammalian neuroblastoma cells","volume":"489","author":"Arcangeli","year":"1995","journal-title":"J. Physiol."},{"issue":"2 Pt 1","key":"10.1016\/j.bbamcr.2015.11.032_bb0580","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jcp.1040850215","article-title":"The effect of potassium on the cell membrane potential and the passage of synchronized cells through the cell cycle","volume":"85","author":"Stambrook","year":"1975","journal-title":"J. Cell. Physiol."},{"issue":"52","key":"10.1016\/j.bbamcr.2015.11.032_bb0585","first-page":"36234","article-title":"Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors","volume":"283","author":"Downie","year":"2008","journal-title":"J. Biolumin. Chemilumin."},{"issue":"10 Pt B","key":"10.1016\/j.bbamcr.2015.11.032_bb0590","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.bbamem.2014.12.008","article-title":"Involvement of potassium channels in the progression of cancer to a more malignant phenotype","volume":"1848","author":"Comes","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"8","key":"10.1016\/j.bbamcr.2015.11.032_bb0595","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2174\/156800909790192400","article-title":"Voltage-dependent potassium channels Kv1.3 and Kv1.5 in human cancer","volume":"9","author":"Bielanska","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"issue":"15","key":"10.1016\/j.bbamcr.2015.11.032_bb0600","doi-asserted-by":"crossref","first-page":"7343","DOI":"10.1158\/0008-5472.CAN-07-0107","article-title":"Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity","volume":"67","author":"Gomez-Varela","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0605","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1186\/1471-2407-14-745","article-title":"In vivo dual targeting of the oncogenic Ether-a-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors","volume":"14","author":"Garcia-Quiroz","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0610","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/bjc.2015.28","article-title":"hERG1 channels drive tumour malignancy and may serve as prognostic factor in pancreatic ductal adenocarcinoma","volume":"112","author":"Lastraioli","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0615","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.1091\/mbc.e04-10-0940","article-title":"Human ether-a-go-go-related gene 1 channels are physically linked to beta1 integrins and modulate adhesion-dependent signaling","volume":"16","author":"Cherubini","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0620","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1038\/srep03308","article-title":"hERG1 channels modulate integrin signaling to trigger angiogenesis and tumor progression in colorectal cancer","volume":"3","author":"Crociani","year":"2013","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbamcr.2015.11.032_bb0625","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/cam4.72","article-title":"Characterization of hERG1 channel role in mouse colorectal carcinogenesis","volume":"2","author":"Fiore","year":"2013","journal-title":"Cancer Med"},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0630","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1158\/1078-0432.CCR-13-2633","article-title":"hERG1 channels regulate VEGF-A secretion in human gastric cancer: clinicopathological correlations and therapeutical implications","volume":"20","author":"Crociani","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0635","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood-2010-01-262691","article-title":"Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers","volume":"117","author":"Pillozzi","year":"2011","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0640","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/leu.2014.26","article-title":"Differential expression of hERG1A and hERG1B genes in pediatric acute lymphoblastic leukemia identifies different prognostic subgroups","volume":"28","author":"Pillozzi","year":"2014","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.bbamcr.2015.11.032_bb0645","doi-asserted-by":"crossref","first-page":"450","DOI":"10.4161\/cbt.24423","article-title":"ZC88, a novel 4-amino piperidine analog, inhibits the growth of neuroblastoma cells through blocking hERG potassium channel","volume":"14","author":"Wei","year":"2013","journal-title":"Cancer Biol. Ther."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0650","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1124\/mol.114.094920","article-title":"New pyrimido-indole compound CD-160130 preferentially inhibits the KV11.1B isoform and produces antileukemic effects without cardiotoxicity","volume":"87","author":"Gasparoli","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0655","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3892\/or.2013.2875","article-title":"Voltage-gated and ATP-sensitive K+ channels are associated with cell proliferation and tumorigenesis of human glioma","volume":"31","author":"Ru","year":"2014","journal-title":"Oncol. Rep."},{"issue":"1\u20133","key":"10.1016\/j.bbamcr.2015.11.032_bb0660","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2010.10.066","article-title":"Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo","volume":"651","author":"Jang","year":"2011","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0665","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/emmm.201200235","article-title":"Inhibitors of mitochondrial Kv1.3 channels induce Bax\/Bak-independent death of cancer cells","volume":"4","author":"Leanza","year":"2012","journal-title":"EMBO Mol Med"},{"issue":"13","key":"10.1016\/j.bbamcr.2015.11.032_bb0670","first-page":"12790","article-title":"A novel potassium channel in lymphocyte mitochondria","volume":"280","author":"Szabo","year":"2005","journal-title":"J. Biolumin. Chemilumin."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0675","article-title":"Targeting a mitochondrial potassium channel to fight cancer","author":"Leanza","year":"2014","journal-title":"Cell Calcium"},{"issue":"7360","key":"10.1016\/j.bbamcr.2015.11.032_bb0680","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nature10230","article-title":"A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter","volume":"476","author":"De Stefani","year":"2011","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bbamcr.2015.11.032_bb0685","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.bbamcr.2015.04.008","article-title":"Structure and function of the mitochondrial calcium uniporter complex","volume":"1853","author":"De Stefani","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0690","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/13816128113199990032","article-title":"Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines","volume":"20","author":"Leanza","year":"2014","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.bbamcr.2015.11.032_bb0695","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1038\/leu.2013.56","article-title":"Clofazimine, Psora-4 and PAP-1, inhibitors of the potassium channel Kv1.3, as a new and selective therapeutic strategy in chronic lymphocytic leukemia","volume":"27","author":"Leanza","year":"2013","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0700","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1159\/000430223","article-title":"Biophysical characterization and expression analysis of Kv1.3 potassium channel in primary human leukemic B cells","volume":"37","author":"Szabo","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0705","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1093\/jac\/dkr444","article-title":"Clofazimine: current status and future prospects","volume":"67","author":"Cholo","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0710","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1152\/physrev.00021.2013","article-title":"Mitochondrial channels: ion fluxes and more","volume":"94","author":"Szabo","year":"2014","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0715","doi-asserted-by":"crossref","DOI":"10.1089\/ars.2014.5979","article-title":"Pseudomonas aeruginosa pyocyanin induces neutrophil death via mitochondrial reactive oxygen species and mitochondrial acid sphingomyelinase","author":"Manago","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"39","key":"10.1016\/j.bbamcr.2015.11.032_bb0720","first-page":"23563","article-title":"A new fungal diterpene induces VDAC1-dependent apoptosis in Bax\/Bak-deficient cells","volume":"290","author":"Huang","year":"2015","journal-title":"J. Biolumin. Chemilumin."},{"issue":"10 Pt B","key":"10.1016\/j.bbamcr.2015.11.032_bb0725","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.bbamem.2014.10.040","article-title":"The mitochondrial voltage-dependent anion channel 1 in tumor cells","volume":"1848","author":"Shoshan-Barmatz","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0730","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00424-004-1255-8","article-title":"The 2P-domain K+ channels: role in apoptosis and tumorigenesis","volume":"448","author":"Patel","year":"2004","journal-title":"Pflugers Arch."},{"issue":"13","key":"10.1016\/j.bbamcr.2015.11.032_bb0735","doi-asserted-by":"crossref","first-page":"7803","DOI":"10.1073\/pnas.1232448100","article-title":"Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function","volume":"100","author":"Pei","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.bbamcr.2015.11.032_bb0740","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076740","article-title":"Blocking KCa3.1 channels increases tumor cell killing by a subpopulation of human natural killer lymphocytes","volume":"8","author":"Koshy","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbamcr.2015.11.032_bb0745","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.2174\/156800911798073069","article-title":"New alkyl-lipid blockers of SK3 channels reduce cancer cell migration and occurrence of metastasis","volume":"11","author":"Girault","year":"2011","journal-title":"Curr. Cancer Drug Targets"},{"issue":"15","key":"10.1016\/j.bbamcr.2015.11.032_bb0750","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1158\/0008-5472.CAN-12-4572","article-title":"Pivotal role of the lipid Raft SK3\u2013Orai1 complex in human cancer cell migration and bone metastases","volume":"73","author":"Chantome","year":"2013","journal-title":"Cancer Res."},{"issue":"39","key":"10.1016\/j.bbamcr.2015.11.032_bb0755","first-page":"25020","article-title":"Calcium release-activated calcium current (ICRAC) is a direct target for sphingosine","volume":"273","author":"Mathes","year":"1998","journal-title":"J. Biolumin. Chemilumin."},{"issue":"24","key":"10.1016\/j.bbamcr.2015.11.032_bb0760","doi-asserted-by":"crossref","first-page":"13795","DOI":"10.1073\/pnas.96.24.13795","article-title":"Stimulation of CD95 (Fas) blocks T lymphocyte calcium channels through sphingomyelinase and sphingolipids","volume":"96","author":"Lepple-Wienhues","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0765","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1164\/rccm.201104-0717OC","article-title":"Lung endothelial Ca2+ and permeability response to platelet-activating factor is mediated by acid sphingomyelinase and transient receptor potential classical 6","volume":"185","author":"Samapati","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0770","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/nrm2329","article-title":"Principles of bioactive lipid signalling: lessons from sphingolipids","volume":"9","author":"Hannun","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"36","key":"10.1016\/j.bbamcr.2015.11.032_bb0775","first-page":"33540","volume":"276","author":"Xu","year":"2001","journal-title":"J. Biolumin. Chemilumin."},{"issue":"23","key":"10.1016\/j.bbamcr.2015.11.032_bb0780","first-page":"20589","article-title":"CD95 signaling via ceramide-rich membrane rafts","volume":"276","author":"Grassme","year":"2001","journal-title":"J. Biolumin. Chemilumin."},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0785","doi-asserted-by":"crossref","first-page":"298","DOI":"10.4049\/jimmunol.168.1.298","article-title":"Ceramide-rich membrane rafts mediate CD40 clustering","volume":"168","author":"Grassme","year":"2002","journal-title":"J. Immunol."},{"issue":"41","key":"10.1016\/j.bbamcr.2015.11.032_bb0790","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.1038\/sj.onc.1209568","article-title":"TRAIL activates acid sphingomyelinase via a redox mechanism and releases ceramide to trigger apoptosis","volume":"25","author":"Dumitru","year":"2006","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0795","doi-asserted-by":"crossref","first-page":"418","DOI":"10.4049\/jimmunol.172.1.418","article-title":"Localization of cystic fibrosis transmembrane conductance regulator to lipid rafts of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation","volume":"172","author":"Kowalski","year":"2004","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0800","doi-asserted-by":"crossref","first-page":"H605","DOI":"10.1152\/ajpheart.00697.2002","article-title":"Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries","volume":"284","author":"Zhang","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0805","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/eji.200324786","article-title":"CD95 death-inducing signaling complex formation and internalization occur in lipid rafts of type I and type II cells","volume":"34","author":"Eramo","year":"2004","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0810","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0006-291X(03)00763-0","article-title":"Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platforms","volume":"305","author":"Bock","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"35","key":"10.1016\/j.bbamcr.2015.11.032_bb0815","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1038\/sj.onc.1206540","article-title":"Ceramide-mediated clustering is required for CD95-DISC formation","volume":"22","author":"Grassme","year":"2003","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0820","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nm823","article-title":"Host defense against Pseudomonas aeruginosa requires ceramide-rich membrane rafts","volume":"9","author":"Grassme","year":"2003","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0825","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1006\/bbrc.2001.5045","article-title":"Molecular mechanisms of ceramide-mediated CD95 clustering","volume":"284","author":"Grassme","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.bbamcr.2015.11.032_bb0830","doi-asserted-by":"crossref","first-page":"7661","DOI":"10.1073\/pnas.94.14.7661","article-title":"Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases","volume":"94","author":"Gulbins","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1638","key":"10.1016\/j.bbamcr.2015.11.032_bb0835","doi-asserted-by":"crossref","first-page":"20130105","DOI":"10.1098\/rstb.2013.0105","article-title":"Regulation of voltage-gated sodium channel expression in cancer: hormones, growth factors and auto-regulation","volume":"369","author":"Fraser","year":"2014","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"issue":"13","key":"10.1016\/j.bbamcr.2015.11.032_bb0840","first-page":"8680","article-title":"Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells","volume":"284","author":"Gillet","year":"2009","journal-title":"J. Biolumin. Chemilumin."},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0845","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/j.bmc.2011.08.061","article-title":"Asymmetric synthesis and evaluation of a hydroxyphenylamide voltage-gated sodium channel blocker in human prostate cancer xenografts","volume":"20","author":"Davis","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0850","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1742-7843.2012.00880.x","article-title":"Oxidative stress in the in vivo DMBA rat model of breast cancer: suppression by a voltage-gated sodium channel inhibitor (RS100642)","volume":"111","author":"Batcioglu","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0855","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.canlet.2012.03.036","article-title":"Voltage-gated sodium channel activity promotes prostate cancer metastasis in vivo","volume":"323","author":"Yildirim","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0860","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12943-014-0277-x","article-title":"The sodium channel-blocking antiepileptic drug phenytoin inhibits breast tumour growth and metastasis","volume":"14","author":"Nelson","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0865","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1476-4598-13-264","article-title":"Ranolazine inhibits NaV1.5-mediated breast cancer cell invasiveness and lung colonization","volume":"13","author":"Driffort","year":"2014","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.bbamcr.2015.11.032_bb0870","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.CIR.0000139333.83620.5D","article-title":"Electrophysiological effects of ranolazine, a novel antianginal agent with antiarrhythmic properties","volume":"110","author":"Antzelevitch","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0875","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2015.03.324","article-title":"Antiarrhythmic properties of ranolazine: a review of the current evidence","volume":"187","author":"Gupta","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0880","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3181\/0711-MR-308","article-title":"An unexpected role for ion channels in brain tumor metastasis","volume":"233","author":"Sontheimer","year":"2008","journal-title":"Exp Biol Med (Maywood)"},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0885","first-page":"4135","article-title":"Chlorotoxin inhibits glioma cell invasion via matrix metalloproteinase-2","volume":"278","author":"Deshane","year":"2003","journal-title":"J. Biolumin. Chemilumin."},{"issue":"4","key":"10.1016\/j.bbamcr.2015.11.032_bb0890","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0306-4522(97)00456-9","article-title":"Expression of voltage-activated chloride currents in acute slices of human gliomas","volume":"83","author":"Ullrich","year":"1998","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0895","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1017\/S1740925X06000044","article-title":"A role for ion channels in glioma cell invasion","volume":"2","author":"McFerrin","year":"2006","journal-title":"Neuron Glia Biol."},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0900","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/smll.200800646","article-title":"Inhibition of tumor-cell invasion with chlorotoxin-bound superparamagnetic nanoparticles","volume":"5","author":"Veiseh","year":"2009","journal-title":"Small"},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0905","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/glia.10083","article-title":"Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin","volume":"39","author":"Lyons","year":"2002","journal-title":"Glia"},{"issue":"2","key":"10.1016\/j.bbamcr.2015.11.032_bb0910","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1517\/17425247.4.2.175","article-title":"Targeted delivery of antitumoral therapy to glioma and other malignancies with synthetic chlorotoxin (TM-601)","volume":"4","author":"Mamelak","year":"2007","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"10.1016\/j.bbamcr.2015.11.032_bb0915","first-page":"39","article-title":"Potent pleiotropic anti-angiogenic effects of TM601, a synthetic chlorotoxin peptide","volume":"30","author":"Jacoby","year":"2010","journal-title":"Anticancer Res."},{"issue":"10","key":"10.1016\/j.bbamcr.2015.11.032_bb0920","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1021\/mp400691z","article-title":"Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes","volume":"11","author":"Qin","year":"2014","journal-title":"Mol. Pharm."},{"issue":"13","key":"10.1016\/j.bbamcr.2015.11.032_bb0925","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1158\/0008-5472.CAN-12-0475-T","article-title":"TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression","volume":"72","author":"Duvvuri","year":"2012","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.bbamcr.2015.11.032_bb0930","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136584","article-title":"Inhibition of calcium-activated chloride channel ANO1\/TMEM16A suppresses tumor growth and invasion in human lung cancer","volume":"10","author":"Jia","year":"2015","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bbamcr.2015.11.032_bb0935","doi-asserted-by":"crossref","first-page":"E1026","DOI":"10.1073\/pnas.1217072110","article-title":"Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling","volume":"110","author":"Britschgi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"17","key":"10.1016\/j.bbamcr.2015.11.032_bb0940","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1158\/1078-0432.CCR-14-0363","article-title":"To \u201cgrow\u201d or \u201cgo\u201d: TMEM16A expression as a switch between tumor growth and metastasis in SCCHN","volume":"20","author":"Shiwarski","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbamcr.2015.11.032_bb0945","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1124\/mol.107.043208","article-title":"Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel","volume":"73","author":"De La Fuente","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.bbamcr.2015.11.032_bb0950","doi-asserted-by":"crossref","first-page":"e0133656","DOI":"10.1371\/journal.pone.0133656","article-title":"Inhibition of ANO1\/TMEM16A chloride channel by idebenone and Its cytotoxicity to cancer cell lines","volume":"10","author":"Seo","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.bbamcr.2015.11.032_bb0955","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1159\/000335850","article-title":"Curcumin blocks Kv11.1 (erg) potassium current and slows proliferation in the infant acute monocytic leukemia cell line THP-1","volume":"28","author":"Banderali","year":"2011","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0960","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fphys.2014.00094","article-title":"Effects of curcumin on ion channels and transporters","volume":"5","author":"Zhang","year":"2014","journal-title":"Front. Physiol."},{"issue":"10 Pt B","key":"10.1016\/j.bbamcr.2015.11.032_bb0965","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.bbamem.2015.03.034","article-title":"Targeting ion channels for cancer therapy by repurposing the approved drugs","volume":"1848","author":"Kale","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"21","key":"10.1016\/j.bbamcr.2015.11.032_bb0970","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.2174\/0929867321666140217122100","article-title":"Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics","volume":"21","author":"Gautam","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0975","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3389\/fonc.2013.00222","article-title":"Tumor targeting via integrin ligands","volume":"3","author":"Marelli","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.bbamcr.2015.11.032_bb0980","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2015.08.022","article-title":"Magnetic nanoparticle-based drug delivery for cancer therapy","author":"Tietze","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488915004164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488915004164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T16:16:47Z","timestamp":1748708207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488915004164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":196,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0167488915004164"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2015.11.032","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological targeting of ion channels for cancer therapy: In vivo evidences","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2015.11.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}